Atıf Formatları
Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

C. Gudiol Et Al. , "Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa," Antimicrobial Agents and Chemotherapy , vol.64, no.4, 2020

Gudiol, C. Et Al. 2020. Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy , vol.64, no.4 .

Gudiol, C., Albasanz-Puig, A., Laporte-Amargós, J., Pallarès, N., Mussetti, A., Ruiz-Camps, I., ... Puerta-Alcalde, P.(2020). Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy , vol.64, no.4.

Gudiol, C. Et Al. "Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa," Antimicrobial Agents and Chemotherapy , vol.64, no.4, 2020

Gudiol, C. Et Al. "Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa." Antimicrobial Agents and Chemotherapy , vol.64, no.4, 2020

Gudiol, C. Et Al. (2020) . "Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa." Antimicrobial Agents and Chemotherapy , vol.64, no.4.

@article{article, author={C. Gudiol Et Al. }, title={Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa}, journal={Antimicrobial Agents and Chemotherapy}, year=2020}